Progress of radiotherapy in oligometastatic non-small cell lung cancer
10.3760/cma.j.cn371439-20231130-00027
- VernacularTitle:寡转移非小细胞肺癌的放疗进展
- Author:
Shuyue LI
1
;
Chenying MA
;
Juying ZHOU
;
Xiaoting XU
;
Songbing QIN
Author Information
1. 苏州大学附属第一医院放疗科,苏州 215006
- Keywords:
Carcinoma, non-small-cell lung;
Neoplasm metastasis;
Radiotherapy, computer-assisted
- From:
Journal of International Oncology
2024;51(3):170-174
- CountryChina
- Language:Chinese
-
Abstract:
The effective local management of oligometastatic non-small cell lung cancer (NSCLC) has the potential to prolong patients' survival. The role of radiotherapy as a local treatment modality in patients with oligometastatic NSCLC, whether as first-line therapy or consolidation therapy, remains uncertain. Several studies have demonstrated that stereotactic ablative radiotherapy can offer clinical benefits for patients with oligometastatic NSCLC without increasing adverse reactions. Furthermore, the exploration of the potential synergistic effects of combining radiotherapy and immunotherapy on extending progression-free survival and overall survival in patients with oligometastatic NSCLC is also a topic worthy of attention.